The mammalian spot test and its use for the testing of potential carcinogenicity of welding fume particles and hexavalent chromium.
Welding fume particles, potassium chromate and cyclophosphamide are tested in the mammalian spot test. Female mice C57BL/6J/BOM9 weeks old have been mated to T-stock male mice and treated with welding fume particles 100 mg/kg, potassium chromate 20 or 10 mg/kg, or cyclophosphamide 10 or 2.5 mg/kg intraperitoneally at day 8, 9 and 10 of pregnancy. The fur of the offspring was checked week 2 through week 5 after birth for coloured spots. The characterisation of the different types of spots are discussed. Welding fume particles 100 mg/kg and potassium chromate 10 mg/kg induce approximately to the same extent as cyclophosphamde 2.5 mg/kg, grayish or brownish spots in tvo screening test for mutagenic and carcinogenic potential of chemicals. The positive results for potassium chromate and cyclophosphamide are in agreement with previous in vitro experiments and confirm the sensitivity of the test. The effect of welding fume particles in this in vivo system suggests a potential risk for humans directly exposed to welding fumes.
D000818:Animals; D002273:Carcinogens; D002840:Chromates / Q000494:pharmacology*; D002857:Chromium / Q000494:pharmacology*; D003520:Cyclophosphamide / Q000494:pharmacology*; D004622:Embryo, Mammalian / Q000187:drug effects*; D005260:Female; D008098:Litter Size / Q000187:drug effects; D008297:Male; D008431:Maternal-Fetal Exchange; D051379:Mice; D009153:Mutagens; D010858:Pigmentation / Q000187:drug effects*; D011247:Pregnancy; D014896:Welding
D002273:Carcinogens; D002840:Chromates; D009153:Mutagens; D002857:Chromium; D003520:Cyclophosphamide